Anne-Claude Gavin

Structural and Computational Biology Unit EMBL Heidelberg 
"Anne-Claude Gavin"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li Y, Kuhn M, Zukowska-Kasprzyk J, et al. (2021) Coupling proteomics and metabolomics for the unsupervised identification of protein-metabolite interactions in Chaetomium thermophilum. Plos One. 16: e0254429
Kastritis PL, Gavin AC. (2018) Enzymatic complexes across scales. Essays in Biochemistry. 62: 501-514
Kastritis PL, O'Reilly FJ, Bock T, et al. (2017) Capturing protein communities by structural proteomics in a thermophilic eukaryote. Molecular Systems Biology. 13: 936
Bock T, Chen WH, Ori A, et al. (2014) An integrated approach for genome annotation of the eukaryotic thermophile Chaetomium thermophilum. Nucleic Acids Research. 42: 13525-33
van Noort V, Seebacher J, Bader S, et al. (2012) Cross-talk between phosphorylation and lysine acetylation in a genome-reduced bacterium. Molecular Systems Biology. 8: 571
Nebreda AR, Gavin AC. (1999) Perspectives: signal transduction. Cell survival demands some Rsk. Science (New York, N.Y.). 286: 1309-10
Gavin AC, Ni Ainle A, Chierici E, et al. (1999) A p90(rsk) mutant constitutively interacting with MAP kinase uncouples MAP kinase from p34(cdc2)/cyclin B activation in Xenopus oocytes. Molecular Biology of the Cell. 10: 2971-86
Dorey K, Barilá D, Gavin AC, et al. (1999) Regulation of human c-Abl tyrosine kinase activity in Xenopus oocytes and acceleration of progesterone-induced G2/M transition by oncogenic forms. Biological Chemistry. 380: 223-30
Gavin AC, Nebreda AR. (1999) A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1. Current Biology : Cb. 9: 281-4
Palmer A, Gavin AC, Nebreda AR. (1998) A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. The Embo Journal. 17: 5037-47
See more...